Valeur en termes de données probantes des informations ... - KCE

More documents

Recommendations

Info

22 EB content of written information from pharmaceutical companies KCE reports 55 GPs and specialists. It was not collected at all by one GP and one specialist. Only two GPs and one specialist collected every journal issue (see appendix). Het Medisch Weekblad / La Semaine Médicale is also a journal that is sent to a large number of GPs and specialists. De Huisarts / le Généraliste is normally sent to all GPs but we can notice that one specialist received it. 3.4.1.4 Way of delivery Table 5. Way of delivery by type of document Post Medical representatives CPD Total Letters 94 1 1 96 Brochures 25 19 2 46 Folders 71 31 3 105 Journals 139 0 0 139 Periodicals 89 2 0 91 Total 418 53 6 477 The Table 5 shows the way of delivery by type of document. Overall, most documents (87,63 %) were received by post. Among documents obtained from medical representatives, folders and brochures were the most represented. Finally, a small number of documents were collected at CPD. No journals nor periodicals/periodicals were received at CPD or from medical representatives, except from two issues of the Framingham on respiratory diseases received from medical representatives.
KCE Reports 55 Written information from pharmaceutical companies 23 Table 6. Way of delivery by type of health professionals Post Medical representatives CPD Total Mdn Q1 Q3 Mdn Q1 Q3 Mdn Q1 Q3 Mdn Q1 Q3 GPs (n = 8) 36 33 40 3 3 12 1 1 1 37 34 46 Specialists (n = 5) 16 14 16 3 2 4 3 3 3 20 18 22 Pharmacists (n = 4) 15 11 17 3 2 4 2 2 2 19 14 20 Total (n = 17) 19 16 35 3 2 5 2 2 3 22 19 35 As shown in Table 6, post is the way of delivery most represented for all health professionals. Other ways of delivery are much less represented.
Page 1 and 2: Valeur en termes de données proban
Page 3 and 4: Valeur en termes de données proban
Page 5 and 6: KCE Reports 55B Informations écrit
Page 13: KCE Reports 55B Informations écrit
Page 16 and 17: 2 Written information from pharmace
Page 24 and 25: 10 Written information from pharmac
Page 86 and 87:
72 Written information from pharmac
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
100 Written information from pharma
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Dépôt légal : D/2007/10.273/13
Page 176:
35. Etude relative aux coûts poten
show all

Valeur en termes de données probantes des informations ... - KCE

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?